Sofosbuvir Not Yet Recruiting Phase 4 Trials for Hepatocellular,Carcinoma Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02959359DAA in the Risk of Recurrence After Curative Treatment of HCC